Here are five points:
1. The patent protects VTI’s modular, in-vivo assembly technology and its motion preservation.
2. Canadian clinical trials have shown InterCushion subdues pain, preserves discs and stops modic changes.
3. In those trials, patients are seeing successful outcomes at five years post-implantation.
4. One of the trial researchers, Dr. Philip de Muelenaere, said: “The 5-year follow-up MRI study proves that the prosthesis had maintained its position, maintained the disc height and kept the patients pain free.”
5. VTI holds more than 25 patents and patent-pending assets.
More articles on MIS:
Minimally invasive vs. open surgery for adult spinal deformity: 6 key notes on fractional curve
Outpatient anterior cervical discectomy and fusion reduces complication rate: 4 study insights
Barrow Brain and Spine incorporates Surgical Theater’s Precision Virtual Reality: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
